Confirm that the cornea is the main source of visual loss
Fuchs disease can coexist with cataract, glaucoma, macular disease or previous eye surgery. A specialist review should determine whether blurred vision and glare are mainly caused by endothelial dysfunction and corneal edema, by the lens, or by more than one problem. Slit-lamp findings, corneal thickness, visual acuity and additional corneal or retinal testing help avoid a procedure-first decision.
Endothelial pump failure can produce edema and morning blur
The corneal endothelium helps move fluid out of the cornea. In Fuchs dystrophy, progressive endothelial-cell dysfunction and corneal guttae can reduce that pump function. As edema develops, patients may notice hazy vision, glare or reduced contrast. Symptoms can be more noticeable after waking because the cornea may be more swollen overnight, although the pattern and severity vary between patients.
Not every early Fuchs diagnosis needs transplantation
A diagnosis of Fuchs dystrophy does not automatically mean surgery. The decision should reflect symptoms, corneal clarity and thickness, endothelial status, visual function and the likely contribution of any cataract. The treating cornea specialist should also consider progression, previous eye procedures and the patient's ability to attend early follow-up.
DMEK selectively replaces the diseased endothelial layer
Heidelberg, Cologne, Freiburg and Erlangen describe DMEK as a central or standard treatment for endothelial corneal disease including Fuchs dystrophy. DMEK transplants the donor Descemet membrane with endothelial cells rather than replacing the full corneal thickness. When anatomy is suitable, this preserves the recipient's anterior cornea and avoids the suture-heavy pathway of a full-thickness penetrating keratoplasty.
DSAEK and other transplant techniques remain relevant in selected eyes
DMEK is not the only posterior lamellar technique. DSAEK transfers donor endothelium together with a thin layer of posterior stroma and can still be considered in selected complex situations. If the cornea has substantial stromal scarring or disease outside the endothelial layer, a different transplant strategy may be necessary. The operation should therefore follow layer-specific assessment rather than the diagnosis label alone.
Cataract and Fuchs disease should be planned together
Cataract is common in the same age group and cataract surgery itself can stress a vulnerable corneal endothelium. Some patients may be managed with cataract surgery alone and observation, some with DMEK first or later, and selected patients may undergo combined cataract surgery and DMEK. University Hospital Cologne is studying combined versus cataract-only strategies in patients with Fuchs dystrophy and cataract, underlining that sequencing is an active clinical decision rather than a one-size-fits-all package.
DMEK uses an air or gas bubble and may require rebubbling
After DMEK, the thin donor tissue is supported against the back of the cornea with an air or gas bubble. Early postoperative positioning, eye-pressure checks and frequent topical medication may be required. If part of the graft detaches, an additional air or gas injection can be needed. International patients should ask how long they should remain near the treating center and how urgent reassessment would be arranged after returning home.
Newer tissue-sparing approaches should not be mistaken for routine standard care
Selected centers are investigating Descemet stripping only (DSO) with medical support such as ROCK-inhibitor drops for carefully selected Fuchs cases. University Hospital Cologne describes this as a study approach, while DMEK remains the established transplant standard for clinically significant endothelial failure. Experimental or highly selected alternatives should therefore be discussed as such and not marketed as an automatic substitute for DMEK.
Send records that show both corneal and lens status
A useful international review should make it possible to judge endothelial disease, edema, cataract and previous surgical risk together.
- Recent slit-lamp ophthalmology report
- Pachymetry / corneal-thickness measurements
- Endothelial cell count or specular microscopy if available
- Corneal topography or tomography if performed
- Current refraction and best-corrected visual acuity
- Description of morning blur, glare and change over time
- Cataract severity and lens status
- Previous cataract, glaucoma, refractive or corneal surgery reports
- Intraocular-pressure history if glaucoma is present
- Current eye drops, especially glaucoma or steroid treatment
Plan the first postoperative weeks before booking return travel
Clarify the first-day and first-week examination schedule, positioning instructions, pressure monitoring, topical steroid plan, warning symptoms and the center's threshold for rebubbling. Long-term endothelial and graft follow-up can often be shared with a local ophthalmologist, but the handover should be agreed with the transplant team rather than assumed.
Official sources
Sources last checked 2026-09-14. Ophthalmic treatment can be time-sensitive, so confirm current recommendations directly with the treating eye team.
- DMEK for Fuchs endothelial dystrophy and other endothelial disease — Heidelberg University Hospital ↗
- DMEK – indications including Fuchs dystrophy — University Hospital Cologne ↗
- Fuchs dystrophy study: Descemet stripping only and ROCK-inhibitor drops — University Hospital Cologne ↗
- Corneal dystrophies – endothelial dystrophy and DMEK — University Medical Center Freiburg ↗
- Corneal transplantation / DMEK for Fuchs dystrophy — University Hospital Erlangen ↗